| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Clear Stone Central Lab is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New York Downtown Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New York Downtown Hospital is based in New York, NY. You can find more information on New York Downtown Hospital at www.downtownhospital.org
Who We Serve We provide services to the loved ones of all people enrolled in the Capital Hospice program - as well as to the larger community - who are coping with grief.
Parkcliffe is a Toledo, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.